We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Wound Care System Treats High Risk Surgical Incisions

By HospiMedica International staff writers
Posted on 09 Oct 2013
Image: The ciSNaP NPWT system with controlled tension relief (Photo courtesy of Spiracur).
Image: The ciSNaP NPWT system with controlled tension relief (Photo courtesy of Spiracur).
An ultraportable negative pressure wound therapy (NPWT) system promotes the healing of a surgical closed incisions (CIs), including those in anatomically challenging locations.

The ciSNaP system with controlled tension relief helps reduce surgical CI complications such as infection and dehiscence by promoting active healing, using the efficacy of NPWT. The system is comprised of a sterile cartridge that provides negative pressure to increase blood flow to the incision site, improving wound healing. The small, silent, single use design delivers therapy without batteries or electricity, using a proprietary spring mechanism that generates consistent, even levels of pressure. A visual indicator displays when the cartridge is full or discharged.

The system includes a controlled tension relief layer with silicone wings that help to approximate wound edges, thus reducing potential risk of dehiscence and minimizing tension on staples and sutures. A proprietary hydrocolloid dressing and antimicrobial gauze offer a protective barrier to minimize potential for infection, eliminating the need for dressing changes. Customizable dressing lengths are available to fit a wide range of incisions, all with a secure seal that allows patient to shower. The ciSNaP system is a product of Spiracur (Sunnyvale, CA, USA).

“Our investment in research and development will continue to produce innovative wound healing solutions such as the new ciSNaP System,” said Gary Restani, president and CEO of Spiracur. “This device combines the proven clinical effectiveness of negative pressure therapy with an advanced controlled tension relief layer to help minimize infection and improve wound healing, offering an ideal solution for patients undergoing complex surgeries.”

“I use the new ciSNaP on my higher-risk surgeries because it provides extra protection and stability to the incision,” said Christopher Bellicini, DO, of Excela Health Orthopedics and Sports Medicine (Greensburg, PA, USA). “In my experience, the new device produces excellent results by completely eliminating the need for daily non-sterile dressing changes during the patient’s hospital stay and instead, promoting successful healing of these high-risk wounds. As a result, the threat of infection and the possibility of dehiscence are minimized considerably.”

NPWT involves application of controlled subatmospheric pressure to the local wound environment. Due to its capacity to promote wound healing, NPWT has become standard practice in the field of advanced wound care. Although the body of evidence showing the beneficial effects of NPWT for healing wounds is accumulating, the precise wound healing mechanisms remain unclear.

Related Links:

Spiracur


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Semi‑Automatic Defibrillator
Heart Save AED (ED300)

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more